Abstract
Get full access to this article
View all access options for this article.
References
1.
Huff JE
,
Hernandez L
. OTC contraceptives. J Am Pharm Assoc 1974 ; NS514 : 122 –30 .
2.
Signh B
,
Cutler JC
,
Utidjian HMD
. Studies on development of a vaginal preparation providing both prophylaxis against veneral diseases and other genital infections and contraception. Br J Venereol Dis 1972 ; 48 : 57 –64 .
3.
Cole CH
,
Lacher TG
,
Bailey JC
,
Fairclough DL
. Vaginal chemoprophylaxis in the reduction of reinfection in women with gonorrhea. Br J Venereol Dis 1982 ; 56 : 314 –8 .
4.
Jick H
,
Hannan MT
,
Stergachis A
,
Heidrich F
,
Perera DR
,
Rothman KJ
. Vaginal spermicides and gonorrhea. JAMA 1982 ; 248 : 1619 –21 .
5.
Stone KM
,
Grimes DA
,
Magder LS
. Personal protection against sexually transmitted diseases. Am J Obstet Gynecol 1986 ; 155 : 180 –8 .
6.
Signh B
,
Postic B
,
Cutler JC
. Virucidal effects of certain chemical contraceptives on type 2 herpesvirus. Am J Obstet Gynecol 1976 ; 126 : 422 –5 .
7.
Asculai SS
,
Weiss MT
,
Rancourt MW
Inactivation of herpes simplex viruses by nonionic surfactants. Antimicrob Agents Chemother 1978 ; 13 : 686 –90 .
8.
Vontver LA
,
Reeves LOC
,
Rattray M
Clinical course and diagnosis of genital herpes simplex virus infection and evaluation of topical surfactant therapy. Am J Obstet Gynecol 1979 ; 133 : 548 –54 .